These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1708319)

  • 21. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
    Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
    J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of human leukocyte antigen E and G in HIV infection.
    Tripathi P; Agrawal S
    AIDS; 2007 Jul; 21(11):1395-404. PubMed ID: 17589185
    [No Abstract]   [Full Text] [Related]  

  • 24. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
    Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
    Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
    J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
    N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
    [No Abstract]   [Full Text] [Related]  

  • 27. Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.
    Siakkou H; Jahn S; Kienzle N; Ulrich R; Grötzinger C; Schneider T; Kohleisen B; Pauli G; Spohn R; Jung G
    Arch Virol; 1993; 128(1-2):81-95. PubMed ID: 7678193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological study of the nef protein from HIV-1 by polyclonal and monoclonal antibodies.
    Kienzle N; Bröker M; Harthus HP; Enders M; Erfle V; Buck M; Müller-Lantzsch N
    Arch Virol; 1991; 118(1-2):29-41. PubMed ID: 2048974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping of murine monoclonal antibodies against human immunodeficiency virus type 1 Nef.
    Otake K; Fujii Y; Tashiro M; Adachi A; Kitoh J
    Exp Anim; 1997 Jan; 46(1):53-8. PubMed ID: 9027472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera.
    Wieland U; Kühn JE; Jassoy C; Rübsamen-Waigmann H; Wolber V; Braun RW
    Med Microbiol Immunol; 1990; 179(1):1-11. PubMed ID: 2184337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is anti-p27nef a useful diagnostic and prognostic marker in HIV-1 infection?
    Marty L; Laperche S; Bouchardeau F; Faucher V; Lefrere JJ; Couroucé AM
    AIDS; 1990 Nov; 4(11):1170-1. PubMed ID: 2282200
    [No Abstract]   [Full Text] [Related]  

  • 33. Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.
    Bahraoui E; Benjouad A; Sabatier JM; Allain JP; Laurian Y; Montagnier L; Gluckman JC
    Blood; 1990 Jul; 76(1):257-64. PubMed ID: 1694699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccination and false positive HIV results.
    Erickson CP; McNiff T; Klausner JD
    N Engl J Med; 2006 Mar; 354(13):1422-3. PubMed ID: 16571889
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of a novel Nef epitope on the surface of HIV type 1-infected cells.
    Yamada T; Iwamoto A
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):1001-9. PubMed ID: 10445812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological detection of attenuated HIV-1 variants with nef gene deletions.
    Greenway AL; Mills J; Rhodes D; Deacon NJ; McPhee DA
    AIDS; 1998 Apr; 12(6):555-61. PubMed ID: 9583594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface.
    Yamada T; Watanabe N; Nakamura T; Iwamoto A
    J Immunol; 2004 Feb; 172(4):2401-6. PubMed ID: 14764710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine specificity of the B-cell epitopes recognized in HIV-1 NEF by human sera.
    Tähtinen M; Gombert F; Hyytinen ER; Jung G; Ranki A; Krohn KJ
    Virology; 1992 Mar; 187(1):156-64. PubMed ID: 1371024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A periodic fluctuation in the false anti-HIV-1 reactivity of blood donors' sera--a worldwide phenomenon?
    Mikulecký M
    Acta Virol; 1991 Jan; 35(1):108. PubMed ID: 1683112
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute Epstein-Barr virus infection and human immunodeficiency virus antibody cross-reactivity.
    Ladizinski B; Sankey C
    Am J Med; 2014 Jun; 127(6):e9-10. PubMed ID: 24608015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.